Amoxicillin and Clavulanate Potassium
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0143-9982 -
Package NDC
0143-9982-01 -
Package NDC
0143-9982-50 -
Package NDC
0143-9982-75 -
Application number
ANDA065191 -
SPL ID
29e9e32b-e9a3-48b5-a1c7-14b3bbe447e5 -
SPL set ID
240bcdcb-31d9-40a0-87e1-bd16264a2e20 -
UNII
23521W1S24 -
UNII
804826J2HU -
RxCUI
617423 -
RxCUI
617430
What the source publishes
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Active ingredients
- Amoxicillin and Clavulanate Potassium
- Form
- POWDER, FOR SUSPENSION
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Amoxicillin and Clavulanate Potassium",
"splId": "29e9e32b-e9a3-48b5-a1c7-14b3bbe447e5",
"labels": [
{
"setId": "240bcdcb-31d9-40a0-87e1-bd16264a2e20",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=240bcdcb-31d9-40a0-87e1-bd16264a2e20",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=240bcdcb-31d9-40a0-87e1-bd16264a2e20"
}
],
"routes": [
"ORAL"
],
"labeler": "Hikma Pharmaceuticals USA Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 mL in 1 BOTTLE (0143-9982-01)",
"package_ndc": "0143-9982-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20071201"
},
{
"sample": false,
"description": "50 mL in 1 BOTTLE (0143-9982-50)",
"package_ndc": "0143-9982-50",
"identifierStatus": "well-formed",
"marketing_start_date": "20071201"
},
{
"sample": false,
"description": "75 mL in 1 BOTTLE (0143-9982-75)",
"package_ndc": "0143-9982-75",
"identifierStatus": "well-formed",
"marketing_start_date": "20071201"
}
],
"productId": "0143-9982_29e9e32b-e9a3-48b5-a1c7-14b3bbe447e5",
"useDomain": "unknown",
"dosageForm": "POWDER, FOR SUSPENSION",
"productNdc": "0143-9982",
"deaSchedule": null,
"genericName": "Amoxicillin and Clavulanate Potassium",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "AMOXICILLIN",
"strength": "400 mg/5mL"
},
{
"name": "CLAVULANIC ACID",
"strength": "57 mg/5mL"
}
],
"applicationNumber": "ANDA065191",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20071201",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175930",
"N0000000202"
],
"upc": [
"0301439981015",
"0301439982012"
],
"unii": [
"23521W1S24",
"804826J2HU"
],
"rxcui": [
"617423",
"617430"
],
"spl_set_id": [
"240bcdcb-31d9-40a0-87e1-bd16264a2e20"
],
"pharm_class_epc": [
"beta Lactamase Inhibitor [EPC]"
],
"pharm_class_moa": [
"beta Lactamase Inhibitors [MoA]"
],
"manufacturer_name": [
"Hikma Pharmaceuticals USA Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0143-9982_29e9e32b-e9a3-48b5-a1c7-14b3bbe447e5"